Literature DB >> 11023127

Persistent cobalamin deficiency causing failure to thrive in a juvenile beagle.

H H Fordyce1, M B Callan, U Giger.   

Abstract

A six-month-old beagle was presented with a three-month history of failure to gain weight, lethargy, intermittent vomiting and seizures. Hypoglycaemia, portosystemic shunt, lead intoxication, gastrointestinal diseases and hereditary metabolic disorders were considered. Laboratory test results of low serum cobalamin (Cbl) concentrations, anaemia, leucopenia and methylmalonic aciduria while the dog was receiving a balanced commercial canine diet were suggestive of a congenital selective Cbl malabsorption. Treatment with repeated injections of parenteral cyanocobalamin (CN-Cbl) at 50 microg/kg every two weeks corrected the Cbl-deficient state and reversed all the clinical abnormalities. Selective Cbl malabsorption has previously been described in giant schnauzers and border collies and represents a unique readily treatable hereditary metabolic disorder.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023127     DOI: 10.1111/j.1748-5827.2000.tb03233.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  11 in total

1.  Failure to thrive and life-threatening complications due to inherited selective cobalamin malabsorption effectively managed in a juvenile Australian shepherd dog.

Authors:  Ashley J Gold; Michael A Scott; John C Fyfe
Journal:  Can Vet J       Date:  2015-10       Impact factor: 1.008

Review 2.  Inherited metabolic disease in companion animals: searching for nature's mistakes.

Authors:  Adrian C Sewell; Mark E Haskins; Urs Giger
Journal:  Vet J       Date:  2006-11-07       Impact factor: 2.688

3.  Prospective long-term evaluation of parenteral hydroxocobalamin supplementation in juvenile beagles with selective intestinal cobalamin malabsorption (Imerslund-Gräsbeck syndrome).

Authors:  Peter Hendrik Kook; C E Reusch; M Hersberger
Journal:  J Vet Intern Med       Date:  2018-03-23       Impact factor: 3.333

Review 4.  Intestinal Stem Cells to Advance Drug Development, Precision, and Regenerative Medicine: A Paradigm Shift in Translational Research.

Authors:  Jonathan P Mochel; Albert E Jergens; Dawn Kingsbury; Hyun Jung Kim; Martín G Martín; Karin Allenspach
Journal:  AAPS J       Date:  2017-12-12       Impact factor: 3.603

5.  Daily oral cyanocobalamin supplementation in Beagles with hereditary cobalamin malabsorption (Imerslund-Gräsbeck syndrome) maintains normal clinical and cellular cobalamin status.

Authors:  Peter H Kook; Martin Hersberger
Journal:  J Vet Intern Med       Date:  2018-12-15       Impact factor: 3.333

Review 6.  Emesis in dogs: a review.

Authors:  C Elwood; P Devauchelle; J Elliott; V Freiche; A J German; M Gualtieri; E Hall; E den Hertog; R Neiger; D Peeters; X Roura; K Savary-Bataille
Journal:  J Small Anim Pract       Date:  2010-01       Impact factor: 1.522

7.  A frameshift mutation in the cubilin gene (CUBN) in Border Collies with Imerslund-Gräsbeck syndrome (selective cobalamin malabsorption).

Authors:  Marta Owczarek-Lipska; Vidhya Jagannathan; Cord Drögemüller; Sabina Lutz; Barbara Glanemann; Tosso Leeb; Peter H Kook
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

8.  Selective intestinal cobalamin malabsorption with proteinuria (Imerslund-Gräsbeck syndrome) in juvenile Beagles.

Authors:  J C Fyfe; S L Hemker; P J Venta; B Stebbing; U Giger
Journal:  J Vet Intern Med       Date:  2014-01-16       Impact factor: 3.333

9.  Degenerative liver disease in young Beagles with hereditary cobalamin malabsorption because of a mutation in the cubilin gene.

Authors:  P H Kook; M Drögemüller; T Leeb; J Howard; M Ruetten
Journal:  J Vet Intern Med       Date:  2014-01-27       Impact factor: 3.333

10.  Oral Cobalamin Supplementation in Dogs with Chronic Enteropathies and Hypocobalaminemia.

Authors:  L Toresson; J M Steiner; J S Suchodolski; T Spillmann
Journal:  J Vet Intern Med       Date:  2015-12-09       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.